---
figid: PMC6710986__gr1
figtitle: Deoxynucleotide salvage and de novo synthesis pathways
organisms:
- Homo sapiens
- Mus musculus
- Escherichia coli
- Oryctolagus cuniculus
- Diaporthe sclerotioides
organisms_ner:
- Mus musculus
- Oryctolagus cuniculus
- Homo sapiens
- Drosophila melanogaster
- Caenorhabditis elegans
pmcid: PMC6710986
filename: gr1.jpg
figlink: /pmc/articles/PMC6710986/figure/f0005/
number: F1
caption: Deoxynucleotide salvage and de novo synthesis pathways. In the deoxynucleotide
  salvage pathways, thymidine (dThd) is phosphorylated by thymidine kinase 1 (TK1)
  in cytosol and by thymidine kinase 2 (TK2) in mitochondria. In contrast, deoxycytidine
  (dCtd) is phosphorylated by deoxycytidine kinase (DCK) in cytosol and by TK2 in
  mitochondria. The purine nucleosides are phosphorylated by DCK in cytosol and by
  deoxyguanoside kinase (DGK) in mitochondria. In the de novo pathway, ribonucleoside
  diphosphates are converted to deoxynucleoside diphosphates by ribonucleotide reductase
  (RNR). Equilibrative nucleoside transporter 1 (ENT1) and 2 (ENT2) transport pyrimidine
  and purine nucleosides across mitochondrial membranes. Purine and pyrimidine nucleotide
  carrier 1 (PNC1) and 2 (PNC2) transport deoxynucleoside diphosphates and deoxynucleoside
  triphosphates across mitochondrial membranes.
papertitle: Bioavailability and cytosolic kinases modulate response to deoxynucleoside
  therapy in TK2 deficiency.
reftext: Carlos Lopez-Gomez, et al. EBioMedicine. 2019 Aug;46:356-367.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9454667
figid_alias: PMC6710986__F1
figtype: Figure
redirect_from: /figures/PMC6710986__F1
ndex: b176b6ad-dedc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6710986__gr1.html
  '@type': Dataset
  description: Deoxynucleotide salvage and de novo synthesis pathways. In the deoxynucleotide
    salvage pathways, thymidine (dThd) is phosphorylated by thymidine kinase 1 (TK1)
    in cytosol and by thymidine kinase 2 (TK2) in mitochondria. In contrast, deoxycytidine
    (dCtd) is phosphorylated by deoxycytidine kinase (DCK) in cytosol and by TK2 in
    mitochondria. The purine nucleosides are phosphorylated by DCK in cytosol and
    by deoxyguanoside kinase (DGK) in mitochondria. In the de novo pathway, ribonucleoside
    diphosphates are converted to deoxynucleoside diphosphates by ribonucleotide reductase
    (RNR). Equilibrative nucleoside transporter 1 (ENT1) and 2 (ENT2) transport pyrimidine
    and purine nucleosides across mitochondrial membranes. Purine and pyrimidine nucleotide
    carrier 1 (PNC1) and 2 (PNC2) transport deoxynucleoside diphosphates and deoxynucleoside
    triphosphates across mitochondrial membranes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Dguok
  - Dgke
  - Dgkb
  - Dgkh
  - Slc29a2
  - Tk2
  - Slc29a1
  - Slc25a33
  - Tk1
  - Parva
  - Dck
  - Ren1
  - Ren2
  - Nr2e3
  - Nt5c2
  - Cux1
  - Emp1
  - SLC29A2
  - TK2
  - TK1
  - DCK
  - DGKB
  - DGUOK
  - DGKE
  - DGKA
  - DGKD
  - DGKG
  - DGKH
  - DGKQ
  - DGKZ
  - DGKI
  - DGKK
  - CMPK2
  - SLC29A1
  - SLC25A33
  - SLC25A36
  - NR2E3
  - NT5C2
  - CUX1
  - NPPA
  - APRT
  - MFAP1
  - EMP1
  - Dgk
  - rdgA
  - Gk2
  - CG34384
  - Amph
  - Ent2
  - Datp
  - btl
  - Tis11
  - apt
  - Ent1
  - Tk
  - htl
  - TBPH
  - dock
  - sti
  - CaMKII
  - fliF
  - Smox
  - ent-2
  - ent-1
  - pnc-1
  - pnc-2
  - dGDP
  - dCDP
  - CDP
  - dGMP
  - GMP
  - AMP
  - TDP
---
